At a glance
- Originator Novo Nordisk
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 21 May 2001 Profile reviewed but no significant changes made
- 29 Jan 1997 No-Development-Reported for Bacterial infections in Denmark (Unknown route)
- 13 Oct 1995 New profile